Shenzhen Birth Cohort Study
Launched by SUN YAT-SEN UNIVERSITY · Feb 1, 2019
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Shenzhen Birth Cohort Study is a research project aimed at understanding how certain environmental factors early in life can impact health both in the short term and long term. This study is taking place in Shenzhen, China, and focuses on issues related to pregnancy complications, gestational diabetes, and even childhood conditions like obesity and neurodevelopmental disorders.
If you are a pregnant woman who is planning to deliver your baby at a specific hospital in Shenzhen and will be living in the area for at least seven years, you might be eligible to participate. To join, you need to be less than 20 weeks pregnant and willing to give your consent for you and your baby to be part of the study. Participants will have regular check-ups at the hospital's child health clinic to monitor their baby’s development until the age of 7. This study aims to gather important information that could help improve the health of future generations.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Pregnant women plan to delivery and participate in child care in our hospital; 2. Pregnant women plan to reside in Shenzhen for at least 7 years; 3. Pregnant women who show interest in the study and agree to provide informed consent; 4. Gestational weeks are less than 20 weeks.Those who will agree that their neonatal will be included in the study and be followed up regularly in our child health clinic until an age of 7 years.
- Exclusion Criteria:
- • Pregnant women who have been pregnant for more than 20 weeks; refuse to participate; unable to guarantee delivery in our hospital or can't participate in child care in our hospital; mentally incapacitated and need guardians; or be unwilling to sign informed consent.
About Sun Yat Sen University
Sun Yat-sen University, a prestigious institution located in Guangzhou, China, is dedicated to advancing medical research and healthcare innovations. As a leading clinical trial sponsor, the university leverages its extensive academic resources and collaboration with top-tier medical professionals to conduct rigorous clinical studies. Committed to improving patient outcomes and contributing to global health knowledge, Sun Yat-sen University focuses on a wide range of therapeutic areas, employing cutting-edge methodologies to ensure the integrity and efficacy of its research initiatives. Through its clinical trials, the university aims to foster scientific advancements and enhance the quality of care provided to patients both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Shenzhen, Guangdong, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials